Literature DB >> 19220525

The new mature red cell parameter, low haemoglobin density of the Beckman-Coulter LH750: clinical utility in the diagnosis of iron deficiency.

E Urrechaga1.   

Abstract

The percentage of hypochromic red cells (%Hypo) is a diagnostic tool that has been used with biochemical markers to diagnose iron disturbances and is incorporated to National Kidney Foundation KDOQI guidelines for monitoring recombinant human erythropoietin therapy. %Hypo measurement has been restricted to analysers manufactured by Siemens. Low haemoglobin density (LHD%), a new parameter provided by Beckman-Coulter, is derived from the traditional mean cell haemoglobin concentration (MCHC), using the mathematical sigmoid transformation [see equation in text]. This study aimed to establish LHD% values in the normal population and in different types of anaemia, to investigate its clinical usefulness in the study of iron status and its correlation with %Hypo. Samples from 449 patients [120 healthy individuals, 86 iron deficiency anaemia (IDA), 102 chronic kidney disease, 58 anaemia of chronic disease and 83 beta-thalassaemia carriers] were run sequentially on the LH 750 (Beckman-Coulter) and Advia 2120 (Siemens) analysers. The reliability of LHD% as a marker of iron deficiency was evaluated on a group of 152 consecutive patients with IDA. Good correlation was observed between %Hypo and LHD%, r(2) = 0.869. Receiver operating characteristic curve analysis for LHD% and the diagnosis of iron deficiency was: cut-off point 4.0%; area under the curve 0.976; sensitivity 95.2%; specificity 93.3%. There was a good level of agreement between LHD% and %Hypo. Both are suitable parameters for determining iron status and its availability for erythropoiesis, with the same clinical significance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220525     DOI: 10.1111/j.1751-553X.2008.01127.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  8 in total

1.  Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure.

Authors:  Kevin Shrestha; Allen G Borowski; Richard W Troughton; Allan L Klein; W H Wilson Tang
Journal:  Congest Heart Fail       Date:  2012-03-13

2.  Clinical Value of Hypochromia Markers in the Detection of Latent Iron Deficiency in Nonanemic Premenopausal Women.

Authors:  Eloísa Urrechaga; Luís Borque; Jesús F Escanero
Journal:  J Clin Lab Anal       Date:  2016-02-22       Impact factor: 2.352

3.  Low hemoglobin density as a measure of iron status.

Authors:  Sharat Damodar; Sneha T Raghunath; Sreedhar Murthy; K J Jayanthi; B R S Latha
Journal:  Indian J Hematol Blood Transfus       Date:  2012-05-26       Impact factor: 0.900

4.  Erythrocyte and Reticulocyte Indices on the LH 750 as Potential Markers of Functional Iron Deficiency.

Authors:  Eloísa Urrechaga; Luís Borque; Jesús F Escanero
Journal:  Anemia       Date:  2010-06-16

5.  Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study.

Authors:  Sigismond Lasocki; Nicolas Chudeau; Thibaut Papet; Deborah Tartiere; Antoine Roquilly; Laurence Carlier; Olivier Mimoz; Philippe Seguin; Yannick Malledant; Karim Asehnoune; Jean François Hamel
Journal:  Crit Care       Date:  2014-09-30       Impact factor: 9.097

6.  Identification of iron status of blood donors by using low hemoglobin density and microcytic anemia factor.

Authors:  Ashutosh Singh; Rajendra Chaudhary; Hem C Pandey; Atul Sonker
Journal:  Asian J Transfus Sci       Date:  2018 Jan-Jun

7.  Diagnostic utility of low hemoglobin density to detect iron deficiency in patients with inflammatory bowel disease.

Authors:  Karima Farrag; Krenare Ademaj; Eleni Leventi; Aysegül Aksan; Jürgen Stein
Journal:  Ann Gastroenterol       Date:  2021-04-02

Review 8.  Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis.

Authors:  Eloísa Urrechaga; Luís Borque; Jesús F Escanero
Journal:  Biomed Res Int       Date:  2013-02-28       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.